← Back to Clinical Trials
Recruiting NCT06551558

NCT06551558 Impact of a Global Warming Strategy of the Patient on the Prevalence of Hypothermia in the Recovering Room

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06551558
Status Recruiting
Phase
Sponsor Poitiers University Hospital
Condition Hypothermia; Anesthesia
Study Type INTERVENTIONAL
Enrollment 174 participants
Start Date 2024-11-08
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
global warmingper operative warming

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 174 participants in total. It began in 2024-11-08 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

50% of patients are hypothermic when they arrive in the recovery room. This hypothermia is potentially at risk for the patient (increases bleeding, risk of infection, risk of cardiac involvement, morbid mortality) and 33,2% steel hypothermic when they discharge from the recovering room. The anesthesia team must prevent these risks through prevention and treatment measures. Currently the majority of patient warming is done only in the operating room, we want to measure the impact of the extension of this warming before and after the surgery on the patient's temperature and on side effects related to hypothermia.

Eligibility Criteria

Inclusion Criteria: * Patient undergoing laparoscopic visceral surgery under general anesthesia with transition to recovering room Exclusion Criteria: * Patient undergoing urgent surgery. * Presence of pre-existing infection (temperature higher than 38°C when receiving the patient in the hospital ward. * Patient with predetermined length of stay in recovering room.

Contact & Investigator

Central Contact

Marion Said

✉ marion.said@chu-poitiers.fr

📞 0549444444

Principal Investigator

Matthieu Boisson, Pu-Ph

PRINCIPAL INVESTIGATOR

Poitiers University Hospital

Frequently Asked Questions

Who can join the NCT06551558 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hypothermia; Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06551558 currently recruiting?

Yes, NCT06551558 is actively recruiting participants. Contact the research team at marion.said@chu-poitiers.fr for enrollment information.

Where is the NCT06551558 trial being conducted?

This trial is being conducted at Poitiers, France.

Who is sponsoring the NCT06551558 clinical trial?

NCT06551558 is sponsored by Poitiers University Hospital. The principal investigator is Matthieu Boisson, Pu-Ph at Poitiers University Hospital. The trial plans to enroll 174 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology